More than 20 million Americans suffer from depression or bipolar disorder. The World Health Organization’s most recent global burden of disease study cites depression as the leading cause of disability worldwide.
So curing these brain diseases in the best way we think possible—by understanding their genetics and biology and by translating sound clinical research into good care---is our constant goal.
Our Hopkins colleagues in the war on cancer have cut a path to its cure: We’re amazed to watch them type a patient’s tumor markers into a computer and get a printout of options that let them tailor treatment and extend life as never before.
That gives us hope as we begin our process.
Like our oncology friends, we must wage our war on three fronts: science, awareness and clinical care.
And like them, we realize that only a strong organization that fosters collaborative research will succeed.
That’s why Hopkins’ Mood Disorders Center is necessary. It provides a setting for collaboration, sound clinical teaching, a site for clinical trials, a place large enough to attract the creativity and spark the drive that will ultimately bring our patients what they need.
J. Raymond DePaulo, M.D.
Henry Phipps Professor,
Chairman, Department of Psychiatry and Behavioral
Kay Redfield Jamison, Ph.D.
Dalio Family Professor in Mood Disorders
Department of Psychiatry and Behavioral Sciences